Premium
Real‐world variability in dabigatran levels in patients with atrial fibrillation: comment
Author(s) -
Douxfils J.,
Chatelain B.,
Dogné J.M.,
Mullier F.
Publication year - 2015
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/jth.12880
Subject(s) - dabigatran , atrial fibrillation , medicine , cardiology , warfarin
J . DOUXF I LS ,* B . CHATELA IN ,† J . -M . DOGN E* and F . MULL I ER† *Department of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur; and †Hematology Laboratory, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for LIfe Sciences (NARILIS), CHU DinantGodinne UcL Namur, Universit e Catholique de Louvain, Yvoir, Belgium
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom